Rare diseases
Investigational molecules
Locations
Paul-Ehrlich-Strasse 15, Waldhaeuser, 72076 Tuebingen, Germany
Immatics Biotechnologies GmbH focuses its clinical development activity on solid tumors, with trials centered on recurrent and refractory disease settings. The research portfolio reflects interest in oncology and tumor-directed immunotherapy.
The sponsor’s trial activity includes patient populations with advanced malignancies across multiple sites in Europe.
Immatics Biotechnologies GmbH runs clinical trials in conditions such as Neoplasm, among others.
Clinical trials run by this sponsor – those enrolling participants first.
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
